Skip to content

Xencor XNCR Net Change in Cash

Net Change in Cash at other companies

Amgen logo
AmgenAMGN
$2.91B+192%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$153.1M-125%
Janux Therapeutics logo
Janux TherapeuticsJANX
-$506K+99.9%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$51.45M-1,849%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$10.27M+142%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$346.7M+1,431%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's net change in cash?
Xencor (XNCR) reported net change in cash of -$40M in Q1 2026.
How has Xencor's net change in cash changed year-over-year?
Xencor's net change in cash decreased by 2969.9% year-over-year, from -$1.3M to -$40M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.